banner

SICKLE CELL DISEASE NEWS

  • email
  • twitter
  • linkedin
  • facebook
By Sickle Cell Disease News - May 05 2022
share
  • email
  • twitter
  • linkedin
  • facebook
FDA Grants Fast Track Status to SCD Gene-editing Therapy GPH101
Graphite Bio’s GPH101, an investigational gene-editing therapy that aims to correct the genetic mutation that causes sickle cell disease (SCD)...
https://media.caboodleai.net/pda/companies/4e18f131-49cb-4cda-b85d-f48a416d1391.png
Website: sicklecellanemianews.com